BRIDGEBIO ONCOLOGY THERAPEUT
62 13F filers hold $BBOT.
Smart Money · top-200 alpha cohort
4 holders · Q1 2026$BBOT is held by 4 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 6.69%, with an average of 1.69% of portfolio. Largest holder: Enavate Sciences GP, LLC at 6.69%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 62 · Source: 13F-HRInsider activity · last 90 days
No Form 4 filings on record for $BBOT in the recent window.
Congress trades · last 90 days
No STOCK Act filings reference $BBOT in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 06:58 UTC.